Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Antares Pharma (NQ: ATRS ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, May 23, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 5.590 (55) Ask (Size) 5.600 (261) Prev. Close 5.590 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding 170,579,682 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Looking Into Antares Pharma's Return On Invested Capital June 08, 2022 Benzinga Pro data, Antares Pharma (NASDAQ:ATRS) reported Q1 sales of $41.56 million. Earnings fell to a loss of $2.32 million, resulting in a 107.1% decrease from last quarter. Via Benzinga ANTARES PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Antares Pharma, Inc. - ATRS May 05, 2022 From Kahn Swick & Foti, LLC Via Business Wire Performance More News Read More ANTARES PHARMA INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Antares Pharma, Inc. - ATRS May 02, 2022 From Kuznicki Law PLLC Via Business Wire ANTARES PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Antares Pharma, Inc. - ATRS April 25, 2022 From Kahn Swick & Foti, LLC Via Business Wire Antares Pharma's Oral Testosterone Treatment Scores FDA Approval March 29, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022 April 14, 2022 Via Benzinga Looking Into Antares Pharma Inc's Recent Short Interest April 14, 2022 Via Benzinga Advancements of CAR-T Cell Therapies Importance Grows While Cancer Cases Increasing April 14, 2022 Via FinancialNewsMedia 12 Health Care Stocks Moving In Wednesday's Intraday Session April 13, 2022 Via Benzinga Why Is Sierra Oncology (SRRA) Stock Up Today? April 13, 2022 Via InvestorPlace Why Antares Pharma Stock Is Soaring Today April 13, 2022 Via Benzinga Why Is BriaCell (BCTX) Stock Moving Today? April 13, 2022 Via InvestorPlace Why Is Antares Pharma (ATRS) Stock Up Today? April 13, 2022 Via InvestorPlace Benzinga's Daily Brief On Trending Tickers For April 13, 2022: JPMorgan, PayPal, Bed Bath & Beyond And More April 13, 2022 Via Benzinga Biotech Stock Sierra Soars On GSK Buyout As Halozyme Nabs Antares April 13, 2022 Via Investor's Business Daily Futures Rise As Earnings Season Begins April 13, 2022 Via Talk Markets The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More April 13, 2022 Via Benzinga ATRS Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Antares Pharma, Inc. Is Fair to Shareholders April 13, 2022 From Halper Sadeh LLP Via Business Wire Morning Brief: Top Stories Dominating Financial Media on Wednesday, April 13 April 13, 2022 Via Benzinga Halozyme Buys Antares In $960M Deal To Create One Drug Delivery, Specialty Product Entity April 13, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday April 13, 2022 Via InvestorPlace The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia March 29, 2022 Via Benzinga The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More March 27, 2022 Via Benzinga Antares Pharma's Return On Capital Employed Overview March 08, 2022 Via Benzinga The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO March 03, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.